Skip to main content
EJNMMI Research
Fig. 4 | EJNMMI Research

Fig. 4

From: Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET

Fig. 4

Comparison of [18F]FCH and [18F]DCFPyL F2TCM model parameters in DIL and benign tissue. Significant difference (P < 0.05) is marked with *. FCH, fluorocholine; DCFPyL, 2-(3-{1-carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid; F2TCM, flow-modified standard two-extravascular-tissue compartment model; DIL, dominant intraprostatic lesion; K1, influx rate; k2, efflux rate constant; k3, binding rate constant; k4, dissociation rate constant; Ki, net uptake rate constant from plasma; DV, distribution volume; SUV, standardized uptake value

Back to article page